Lifeboat Foundation

When it comes to delivering drugs to the body, a major challenge is ensuring that they remain in the area they’re treating and continuing to deliver their payload accurately. While major strides have been made in delivering drugs, monitoring them is a challenge that often requires invasive procedures like biopsies.

Researchers at NYU Tandon led by Jin Kim Montclare, Professor of Chemical and Biomolecular Engineering, have developed proteins that can assemble themselves into fibers to be used as therapeutic agents for the potential treatments of multiple diseases.

These biomaterials can encapsulate and deliver therapeutics for a host of diseases. But while Montclare’s lab has long worked on producing these materials, there was once a challenge that was hard to overcome—how to make sure that these proteins continued to deliver their therapeutics at the correct location in the body for the necessary amount of time.

Superconductors have intrigued physicists for decades. But these materials, which allow the perfect, lossless flow of electrons, usually only exhibit this quantum-mechanical peculiarity at temperatures so low—a few degrees above absolute zero—as to render them impractical.

A research team led by Harvard Professor of Physics and Applied Physics Philip Kim has demonstrated a new strategy for making and manipulating a widely studied class of higher-temperature superconductors called cuprates, clearing a path to engineering new, unusual forms of superconductivity in previously unattainable materials.

Using a uniquely low-temperature device fabrication method, Kim and his team report in the journal Science a promising candidate for the world’s first high-temperature, superconducting diode—essentially, a switch that makes current flow in one direction—made out of thin cuprate crystals.

In this very special episode of Jay Leno’s Garage, Jay is once again joined by Tesla’s Head of Design, Franz von Holzhausen who along with Tesla’s Vice President of Vehicle Engineering, Lars Moravy, bring with them this very special 2024 Tesla Cybertruck Foundation Series, aka, the CYBERBEAST!

Advances in Civil Engineering Using Recycled Concrete Powder, Waste Glass Powder, and Plastic Powder to Improve the Mechanical Properties of Compacted Concrete: Cement Elimination Approach Erfan Najaf and Hassan Abbasi.

International Journal of Rotating Machinery Experimental and Numerical Studies of the Film Cooling Effectiveness Downstream of a Curved Diffusion Film Cooling Hole Fan Yang and Mohammad E. Taslim.

Companies and countries are in a race to develop quantum computers. The machines could revolutionize problem solving in medicine, physics, chemistry and engineering.

The reactor uses tiny balls of fuel and heats gas to generate electricity.

In what can be termed a significant achievement in the development of next-generation nuclear reactor technology, China claims to have successfully commissioned the world’s first Generation IV commercial nuclear reactor.

Continue reading “World’s first Generation IV nuclear reactor gets operational in China” »

Batteries that exploit quantum phenomena to gain, distribute and store power promise to surpass the abilities and usefulness of conventional chemical batteries in certain low-power applications. For the first time, researchers, including those from the University of Tokyo, take advantage of an unintuitive quantum process that disregards the conventional notion of causality to improve the performance of so-called quantum batteries, bringing this future technology a little closer to reality.

When you hear the word “quantum,” the physics governing the subatomic world, developments in quantum computers tend to steal the headlines, but there are other upcoming quantum technologies worth paying attention to. One such item is the quantum battery which, though initially puzzling in name, holds unexplored potential for sustainable energy solutions and possible integration into future electric vehicles. Nevertheless, these new devices are poised to find use in various portable and low-power applications, especially when opportunities to recharge are scarce.

At present, quantum batteries only exist as laboratory experiments, and researchers around the world are working on the different aspects that are hoped to one day combine into a fully functioning and practical application. Graduate student Yuanbo Chen and Associate Professor Yoshihiko Hasegawa from the Department of Information and Communication Engineering at the University of Tokyo are investigating the best way to charge a quantum battery, and this is where time comes into play. One of the advantages of quantum batteries is that they should be incredibly efficient, but that hinges on the way they are charged.

University of Wisconsin–Madison engineers have used a spray coating technology to produce a new workhorse material that can withstand the harsh conditions inside a fusion reactor.

The advance, detailed in a paper published recently in the journal Physica Scripta, could enable more efficient compact fusion reactors that are easier to repair and maintain.

“The fusion community is urgently looking for new manufacturing approaches to economically produce large plasma-facing components in fusion reactors,” says Mykola Ialovega, a postdoctoral researcher in nuclear engineering and engineering physics at UW–Madison and lead author on the paper. “Our technology shows considerable improvements over current approaches. With this research, we are the first to demonstrate the benefits of using cold spray coating technology for fusion applications.”

Johns Hopkins researchers have identified minuscule particles that supercharge therapeutic cancer vaccines, which train the immune system to attack tumors. These new lipid nanoparticles—tiny structures made of fat—not only stimulate a two-pronged immune system response that enhances the body’s ability to fight cancer but also make vaccines more effective in targeting tumors.

“This research marks a pivotal turning point in our understanding of how lipid nanoparticles can be harnessed to optimize anticancer immunity,” said Hai-Quan Mao, director of Johns Hopkins’ Institute for NanoBioTechnology and professor in the Whiting School of Engineering’s Department of Materials Science and Engineering. “Our findings unlock new avenues for enhancing the efficacy of RNA-based treatments for cancer and infectious diseases.”

The team’s results appear in Nature Biomedical Engineering.